[
  {
    "ts": null,
    "headline": "Assessing Exact Sciences After 77.5% YTD Surge and Abbott Deal Outlook",
    "summary": "If you have been wondering whether Exact Sciences is still worth buying after its huge run, you are not alone. This breakdown is designed to help you decide if the current price makes sense. The stock has climbed to around $101.06, logging a powerful 45.1% gain over the last month and a 77.5% jump year to date, even though the last 5 years still show a -22.0% total return. Investors have been reacting to a steady stream of developments around Exact Sciences, including ongoing adoption of its...",
    "url": "https://finnhub.io/api/news?id=6999a1fe1ac4f833409adb9bab6a151a4737d4ef514fe85342d7eececc63ab37",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1764997728,
      "headline": "Assessing Exact Sciences After 77.5% YTD Surge and Abbott Deal Outlook",
      "id": 137715716,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "If you have been wondering whether Exact Sciences is still worth buying after its huge run, you are not alone. This breakdown is designed to help you decide if the current price makes sense. The stock has climbed to around $101.06, logging a powerful 45.1% gain over the last month and a 77.5% jump year to date, even though the last 5 years still show a -22.0% total return. Investors have been reacting to a steady stream of developments around Exact Sciences, including ongoing adoption of its...",
      "url": "https://finnhub.io/api/news?id=6999a1fe1ac4f833409adb9bab6a151a4737d4ef514fe85342d7eececc63ab37"
    }
  }
]